Cholinergic stimulation of arachidonic acid and phosphatidic acid metabolism in C62B glioma cells by DeGeorge, J J et al.
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
0 1986 by The American Society of Biological Chemists, Inc 
Val. 261, No. 7, Issue of March 5, pp. 3428-3433, 1986 
Printed in U.S.A. 
Cholinergic  Stimulation of Arachidonic Acid and Phosphatidic Acid 
Metabolism in C62B Glioma  Cells* 
(Received for publication, May 22,1985) 
Joseph J. DeGeorgeS, Pierre MorellS$lI,  Ken D. McCarthy 11, and  Eduardo G .  Lapetina** 
From  the $Biological Sciences  Research  Center,  §Department of Biochemistry  and  Nutrition,  and I( Department of Pharmacology, 
University of North Carolina at Chapel  Hill,  Chapel  Hill, North Carolina  27514  and  the ** Wellcome  Research  Laboratories, 
Department of Molecular  Biology,  Research  Triangle  Park, North Carolina  27709 
Glioma C62B cells were incubated for 18 h  with [ l -  
14C]arachidonic acid. Most (80%) of the added [1-14C] 
arachidonic acid was taken  into  the  intracellular pool; 
less than 1% of the intracellular [l-’4C]arachidonic 
acid remained unesterified; the rest was present in 
glycerophospholipids. Acetylcholine stimulation of the 
prelabeled cells resulted in the  rapid accumulation of 
free [ l-14C]arachidonic  acid, presumably liberated by 
hydrolysis from phospholipids. Labeled unesterified 
[ 1-I4C ]arachidonic acid peaked by 90 s and  returned 
to basal levels by 5 min. Paralleling  the  transient  in- 
crease of unesterified  [l-14C]arachidonic acid were  in- 
creases  in level of radioactivity  in an unidentified li- 
poxygenase metabolite of arachidonic acid and of ra- 
dioactive phosphatidic acid. The release of arachidonic 
acid induced by acetylcholine or carbachol was blocked 
by muscarinic but not nicotinic receptor antagonists; 
adrenergic or histaminergic receptor agonists were 
ineffective at stimulating  arachidonic acid liberation. 
In  contrast  to  the  transient  effects of stimulation  with 
cholinergic agonists, stimulation  with  the  divalent ca- 
tion ionophore A23187  resulted  in a linear  increase in 
the accumulation of liberated  arachidonic acid for at 
least 1 h. Furthermore,  the  pattern of metabolites syn- 
thesized from arachidonic acid in response to iono- 
phore stimulation was more complex than that ob- 
served following cholinergic stimulation  and included 
also several metabolites derived from cyclooxygenase 
activity. We conclude that muscarinic receptor ago- 
nists rapidly induce specific changes in arachidonic 
acid and phosphatidic acid metabolism in a glioma cell 
line  and suggest that  similar responses may occur in 
glial cells and play a physiologically significant role in 
neural metabolism. 
The importance of arachidonic acid metabolites as  inter- 
mediates in  the transmission of signals has been established 
in a number of cellular systems. Although definitive evidence 
concerning the role of arachidonic acid metabolites is less for 
neural systems than  it is for other tissues, it appears that 
prostaglandins PGE2,’ PGD2, and PGF2, may act  to modulate 
* This work  was supported by United States Public Health Service 
Grants NS07166, NS11615, NS20212, and HD03110. The costs of 
publication of this article were defrayed in part by the payment of 
page charges. This article  must therefore be hereby marked “aduer- 
tisement” in accordance with 18 U.S.C. Section 1734  solely to indicate 
this fact. 
ll To whom correspondence should be addressed. 
‘The abbreviations used are: PGEz, prostaglandin Ez; 6-keto- 
PGF1,, 6-keto-prostaglandin F1,;  PGF,,, prostaglandin Fz,; PGDz, 
prostaglandin Dz; BME, basal medium  Eagle’s; 5-HETE, 5-hydrox- 
yeicosatetraenoic acid; 12-HETE, 12-hydroxyeicosatetraenoic acid; 
HHT, 12-hydroxy-5,8,10-hepadecatrienoic acid; Hepes, N-2-hydrox- 
yethylpiperazine-N’-2-ethanesulfonic acid TLC,  thin-layer  chroma- 
tography. 
neurotransmission both  in the central (Bergstrom et al., 1973; 
Hillier and Templeton, 1980; Hayaishi, 1983) and peripheral 
(Hedqvist, 1973; Brody and Kadowitz, 1974; Hemker and 
Aiken, 1980) nervous system. Furthermore, in several neural 
preparations a variety of stimuli, including application of 
neurotransmitter receptor agonists (Lunt and Rowe, 1971; 
Mallorga et al., 1980; Snider et al., 1984), have been observed 
to cause the liberation of arachidonic acid from esterified 
pools and  result  in the formation of arachidonic acid metab- 
olites (for review see Wolfe, 1982). In mixed  cell preparations 
of neural tissue, it is difficult to relate the presence of a 
particular eicosanoid to a specific cell class. However, the 
physiological relevance of arachidonic acid metabolism by 
neurons is suggested by the observations that purified syn- 
aptosomal preparations have been shown to respond to de- 
polarization with altered arachidonic acid metabolism (Brad- 
ford et al., 1983). Similar approaches have not yet been 
attempted using homogenous preparations of cells of glial 
origin. 
A number of recent studies indicate that glial cells may 
exhibit  neurotransmitter receptors. The demonstration that 
cultures of both primary glial cells (McCarthy and de  Vellis, 
1978; van Calker et al., 1983; Rougon et al., 1983) and glial 
cell lines (Clark and  Perkins, 1971, Bottenstein  and de  Vellis, 
1978) respond to neurotransmitter stimulation with altera- 
tions  in cyclic nucleotide metabolism suggests the possibility 
that, in uiuo, glial cells may respond to neurotransmitters 
released by neurons. The present  study was conducted to  test 
the hypothesis that, in addition to changes in  cyclic nucleotide 
levels, cells of glial origin respond to neurotransmitters with 
alterations  in arachidonic acid metabolism. We have demon- 
strated  that cholinergic stimulation of a  rat glioma  cell line, 
C62B, induces the liberation of arachidonic acid and the 
accumulation of phosphatidic acid and  a lipoxygenase metab- 
olite of arachidonic acid. 
EXPERIMENTAL PROCEDURES 
Materials 
Basal medium  Eagle’s (BME)  and fetal calf serum were purchased 
from Gibco Laboratories (Grand Island Biological Co., Grand Island, 
NY). [l-’4C]arachidonic acid (58 mCi/mmol) was purchased from 
Amersham Corp. Prostaglandin standards and phosphoIipase AZ 
(from naja naja venom), esculetin, nordihydroguaiaretic acid, and 
indomethacin were obtained from Sigma. LK6DF and LK5D thin- 
layer chromatography (TLC) plates were purchased from Whatman 
(Clifton, NJ).  Standard for 5-HETE was generously provided by Dr. 
H. White (The Wellcome Research Laboratories, Research Triangle 
Park, NC).  Standards for HHT  and  12-HETE were prepared from 
platelets as previously reported (Lapetina and Cuatrecasas, 1979). All 
other materials were reagent grade. 
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Methods 
Cell Culture Conditions-The culture medium for C62B cells con- 
sisted of BME supplemented with 5% (v/v)  fetal calf serum, 1 mM 
glucose, 2 mM L-glutamine, 50 units/ml penicillin, and 50 pg/ml 
streptomycin. Cells were  grown in 20 ml of this culture medium in 75 
cmz Corning culture flasks in  a humidified environment of 5% COZ, 
95% air a t  37 "C. The medium was changed every 3-4 days until the 
cells reached confluency, at which time the medium was changed 
every second day. 
[lI-'4C]Arachidonate  Labeling of C62B  Cells-Confluent cultures of 
cells were harvested by incubating cells for 5 min with 0.05% trypsin 
in BME and mechanically dislodging cells from the culture dish 
surface. Trypsinization of harvested cells was stopped by addition of 
an equal volume of culture medium containing  fetal calf serum. The 
cells were centrifuged for 5 min at 100 X g, and the pellet was 
resuspended in fresh complete medium (3.5 X lo5 cells/ml). Portions 
(1 ml) of the cell suspension were seeded into sterile 20-ml glass 
scintillation vials. The culture vials were incubated as indicated above 
for 24  h. The incubation medium was  removed  by aspiration and  the 
cells labeled by incubation for 18 h  in 0.75 ml of fresh culture medium 
containing 0.2 pCi [l-14C]arachidonic acid/vial. Prior to  treatment of 
cells with receptor agonists, the [l-'4C]arachidonic acid-containing 
culture medium was removed, and the cultures were rinsed three 
times with 1 ml of pH 7.2 BME containing 30 mM Hepes. The final 
rinse was removed, 0.70  ml of the same medium was added, and  the 
vials were gased with 5% CO,, 95% air and placed in a 37 "C water 
bath. 
Effects of Inhibitors on Arachidonate Metabolism-Homogenates of 
C62B (3.0 X lo6 cells/ml) were prepared in 30 mM Hepes-buffered 
BME. Portions (200 pl) of the cell homogenate were added to culture 
tubes containing arachidonic acid metabolism inhibitors in 5 g1 of 
ethanol:HzO (1:l) and incubated for 5 min at  room temperature. 
Control incubations contained homogenate and vehicle alone. The 
ionophore A23187  (2.5 p ~ )  and [l-'4C]arachidonic acid (0.2 pCi) were 
added (addition of the ionophore resulted in maximal stimulation of 
synthesis of all arachidonic acid metabolites so that inhibition could 
be most easily quantitated). The incubation was continued for 5 min 
at 37 "C. Controls, containing homogenate and vehicle only, were 
placed in  a boiling water bath for 5 min prior to addition of [l-"C] 
arachidonic acid to measure nonenzymatic conversion of arachidonic 
acid to metabolites. Lipids were extracted and separated as outlined 
below. 
Treatment with Neurotransmitter Receptor Ligands-Solutions of 
receptor ligands were prepared in Hepes-buffered BME (the rinse 
medium) immediately prior to use; the concentrations were adjusted 
so that addition of 50-pl aliquots to  the cultures gave the desired final 
concentration. The cultures were then incubated at 37 "C for the 
times indicated in the figure legends. In experiments where acetyl- 
choline was used as  the receptor agonist, the final incubation medium 
contained eserine (100 p ~ )  to inhibit acetylcholine esterase. Acetyl- 
choline receptor antagonists were added to  the final incubation me- 
dium 5 min prior to  treatment of cultures with receptor agonists. 
Lipid Analysis-Lipid extracts were prepared as previously re- 
ported (Lapetina and Cuatrecasas, 1979). Incubations were stopped 
by addition of 2.8  ml of ch1oroform:methanol (1:2) (and placing the 
vial in  a  sonicating bath for 1 min to separate the tissue from the 
glass). The sonicated cell samples were transferred to centrifuge 
tubes, and 0.9 ml of chloroform and 0.9 ml of water were added. 
Following agitation on a Vortex shaker, the phases were separated by 
centrifugation, and  the organic phase was  removed and evaporated 
to dryness under a stream of nitrogen at  room temperature. The 
resulting sample residue was dissolved in 50 p1 of chloroform, and 20- 
p1 portions were applied to Silica Gel LK6DF TLC plates. Arachidonic 
acid and  its metabolites were separated from esterified lipids, using a 
solvent consisting of the upper phase obtained after phase separation 
of a  mixture of ethyl acetate:isooctane:acetic acidH,O (93:47:20:100). 
Arachidonic acid and  its metabolites were separated with the follow- 
ing RF values in this system: arachidonic acid, 0.77; HHT, 0.60; 5- 
HETE, 0.57; PGDz, 0.31;  PGE,,  0.21;  6-keto-PGF1,/PGF,,,  0.12; 
phosphatidic acid, 0.05. Separation of  PGF,, from 6-keto-PGF1, was 
achieved using the same solvents in the ratio of 90:5020100  (Tansik 
et al., 1978) with LK5D TLC plates. The resultant RF values for 
PGFz, and 6-keto-PGF1, were 0.16 and 0.11, respectively.-A second 
system, petroleum ether:diethyl ether:acetic acid (50501) was used 
to  better resolve 5-HETE from HHT  and arachidonic acid. In this 
system, RF values were arachidonic acid, 0.66; HHT, 0.33; and 5-  
HETE, 0.24. 
Separation of phospholipids was performed on Silica Gel LK5D 
TLC plates developed in ch1oroform:methanol:petroleum etheracetic 
acidboric acid in the ratio 4020:3010:1.8 (v/v/v/v/w) (Gilfillan et 
al., 1983). The [l-'4C]arachidonyl lipids were visualized by autora- 
diography and tentatively identified by co-chromatography with 
standards detected with iodine vapor. Quantification of radioactivity 
incorporated into lipids was determined by scraping regions of the 
TLC plates and liquid scintillation counting. 
Hydrolysis of Phospholipids by Phospholipase Az- Pooled lipid 
extracts from control cultures labeled with [l-'4C]arachidonic acid 
were dried under nitrogen. The residues were  dissolved in 0.75  ml  of 
diethyl ether:methanol (982), and 50 p1 of phospholipase A, (1 mg/ 
ml in water) and 50  pl of pH 7.2 Hanks' balanced salt solution were 
added. The samples were  vigorously  mixed and incubated with gentle 
shaking overnight a t  room temperature. Hydrolysis of phospholipids 
was quantiated by isolation of esterified radioactive fatty acid by 
TLC  and determination of radioactivity as noted above. The radio- 
activity in cellular phospholipids was almost completely (more than 
95%) converted to unesterified arachidonic acid by phospholipase A, 
treatment. Control samples incubated in the absence of enzyme 
released less than 3% of the radioactivity from phospholipids. 
RESULTS 
Incorporation of Arachidonic Acid into C62B Cells-When 
C62B  glioma cells were incubated for 18  h in the presence of 
[l-14C]arachidonic acid, 80 5 1.5% (n  = 14) of the radioactiv- 
ity added was present  in the cellular pool (not removed by 
rinsing the cultures). Of that radioactivity incorporated into 
cells, most (84-94%) was present in phospholipids and was 
esterified in the 2-position. Some [l-'4C]arachidonic acid (5- 
15%) was esterified in neutral lipids, while less than 0.5% 
remained as free arachidonic acid. The radioactivity that was 
not cell-associated and remained in (or was released into)  the 
incubation medium was primarily free arachidonic acid (65%), 
while about 30% was present  as the lipoxygenase metabolite 
5-HETE. Several minor radioactive bands were also resolved 
on the chromatographic plates of the culture medium lipids. 
However, these were also present  in similar amounts in me- 
dium incubated for 18 h in the absence of cells. 
Cholinergic Stimulation of Arachidonic  Acid Metabolkm- 
Treatment of prelabeled C62B cells with 1 mM acetylcholine 
increased the liberation of radioactive arachidonic acid from 
esterified cellular pools and  the accumulation of radioactive 
arachidonic acid metabolite and radioactive phosphatidic acid 
(Figs. 1 and 2). Measurable accumulation of unesterified [I- 
14C]arachidonic acid occurred within 15 s of exposure to 
acetylcholine; the accumulation was maximal by  60-90 s, and 
levels  of unesterified radioactive arachidonic acid returned to 
base-line within 5 min. The return to basal levels  was not the 
result of hydrolysis and  eventual depletion of acetylcholine 
from the  treatment medium, as  the hydrolysis of acetylcholine 
was presumably inhibited by eserine. Furthermore, the same 
time course of radioactive arachidonic acid accumulation was 
observed when the nonhydrolyzable cholinergic receptor ag- 
onist, carbachol, was used. At  the peak of arachidonic acid 
accumulation, approximately 4% of the total radioactivity 
incorporated into glycerolipids had been liberated. The 
amount of [l-'4C]arachidonic acid accumulating in response 
to cholinergic stimulation was variable at  the 90-s time point 
by a factor of 2 from experiment to experiment. This might 
be due to uncontrolled variables which shifted the time course 
of the peak response; inspection of Fig. 3 reveals that a 15-s 
difference in sampling time (or combination of variables such 
as  batch to batch cell differences resulting in similar variabil- 
ity) would result in such data  scatter. Radioactive phospha- 
tidic acid rose in parallel with arachidonic acid accumulation 
for 60 s and remained at  an elevated level for over 15 min, 
long after the pool of unesterified radioactive lipids (arachi- 
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FIG. 1. Autoradiograph of arachidonic acid and its metab- 
olites  following cholinergic stimulation of C62B cells. Lipid 
extracts were prepared and lipids separated as indicated under “Meth- 
ods.” Cultures of C62B cells were incubated in the presence of 1.0 
mM acetylcholine for the times indicated; controls were incubated in 
the absence of neurotransmitter. The abbreviations used in the figure 
are: AA, arachidonic acid; LM, lipoxygenase metabolite; PA, phos- 
phatidic acid TG, triglyceride, DG, 1,2-diacylglycerol, PAR, preabsor- 
bent region (containing primarily phospholipids which did not mi- 
grate in the solvent system used). 
TIME (MIN) 
FIG. 2. Time course of accumulation of liberated radioac- 
tive arachidonic acid, phosphatidic acid, and lipoxygenase 
metabolite during cholinergic stimulation. Cultures of C62B 
cells were incubated in the presence of  1.0 mM acetylcholine for the 
times indicated (arachidonic acid, 0,  phosphatidic acid, 0; lipoxygen- 
ase metabolite, A).  Cultures  incubated in the absence of acetylcholine 
for various periods of time fall within the S.E. of the time zero 
controls and  are  thus not included. Each value is the mean f S.E./ 
culture of three to five separate experiments, each performed in 
duplicate. 
donic acid metabolite and arachidonic acid) had  returned to 
base-line. 
The stimulation of [l-’4C]arachidonic acid liberation by 
acetylcholine was detectable at  concentrations of agonists as 
low as 5 pM (Fig. 3, note the presence of 100 p~ eserine to 
inhibit acetylcholinesterase). The response was maximal at  
approximately 1.0 mM acetylcholine. Carbachol, while not as 
potent  as acetylcholine, had a  similar  concentration-depend- 
ent effect (Fig. 3 and  Table I). The concentration response 
curves for cholinergic stimulation (levels of metabolite a t  1 
min as a  function of the concentration of cholinergic agonist) 
were nearly identical for arachidonic acid and phosphatidic 
LL L ‘  1 I I I 
0 ’ ,001 .01 0.1 1.0 10.0 
AGONIST CONCENTRATION [mM] 
FIG. 3. Liberation of ratioactive arachidonic acid as a func- 
tion of cholinergic receptor agonist concentration. Prelabeled 
C62B cells were incubated in the absence or presence of acetylcholine 
(0) or carbachol (0) for 1 min. Each value represents the mean of 
two or three experiments each performed in duplicate. Results are 
expressed as  the percentage of unesterified radioactive arachidonic 
acid present in control  cultures (not treated with agonists) at time 
zero. 
TABLE I 
Effects of cholinergic receptor agonists and antagonists on [“CJ 
arachidonate liberation from C62B glioma cells 
Cultures of C62B cells were prelabeled with [l-’4C]arachidonic acid 
(AA) and treated with receptor agonists and antagonists as indicated 
(“Methods”). Incubations were stopped after 1 min and lipids pre- 
pared as indicated (“Methods”). 
Treatment Free [“CIAA 
Buffer 
Acetylcholine 
1 x 10-~ M
1 x 10-4 M 
1 x 10-3 M 
Acetylcholine 
5 x 10-~ M 
5 X M plus atropine, 1 X 10-~ M 
5 X M plus atropine, 1 X lo-’ M 
5 X M plus atropine, 1 X 10-~ M 
5 X M plus d-tubocurarine 1 X M 
1 x 10-~ M 
1 x 10-4 M 
1 x 10-~ M 
Oxotremorine 
1 x 10-~ M 
1 x 10“ M 
1 x 10-~ M 
1 x 10-5 M 
1 x 10“ M 
1 x 10-3 M 
Carbachol 
Pilocarpine 
cpmlsample i S. E. 
(n = 4)  
2062 f 98 
3150 f 183 
4582 f 230 
5550 f 147 
4820 f 250 
3950 f 425 
2752 f 120 
1927 f 128 
5927 f 532 
1935 f 150 
2785 * 273 
5678 f 782 
2160 f 180 
2115 f 290 
2002 f 188 
1995 f 158 
1930 f 68 
1852 f 32 
acid accumulation (data  not shown). Although the accumu- 
lation of the unidentified metabolite was  low, 10% of that of 
arachidonic acid, the maximal accumulation of the metabolite 
also occurred at 1.0 mM acetylcholine. 
The cholinergic stimulation of the arachidonic acid libera- 
tion response was specific for muscarinic receptor activation 
(Table I). Low concentrations of the muscarinic receptor 
antagonist, atropine (1-10 nM) inhibited the acetylcholine 
stimulation of arachidonic acid accumulation. Incubation with 
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a nicotinic receptor antagonist d-tubocurarine (1.0 PM), how- 
ever, failed to prevent the acetylcholine-stimulated response. 
It was of interest that while carbachol and acetylcholine 
stimulated the liberation of radioactive arachidonic acid at  
low concentrations, the muscarinic receptor agonists pilocar- 
pine and oxotremorine were ineffective promoters of this 
process, even at  concentrations as high as 1.0 mM. The 
possibility of an adrenergic response was tested since a- and 
8-adrenergic receptor agonists have been shown to stimulate 
arachidonic acid release in some cells (Leslie, 1976; Levine 
and Moskowitz, 1979), and C62B cells exhibit both a- and p- 
adrenergic receptors (Bottenstein  and de Vellis, 1978). Nei- 
ther norepinephrine, an agonist for both a- and @-receptors, 
nor the 8-selective receptor agonist, isoproterenol, increased 
the liberation of arachidonic acid (the assays were conducted 
at 1 and 15 min time points over the 0.1-25 p M  range). 
Histamine (1 p ~ - l  mM) likewise failed to increase arachi- 
donic acid metabolism in C62B cells. 
The metabolic pathway involved in production of the uni- 
dentified arachidonic acid metabolite accumulating as the 
result of cholinergic stimulation was identified by use of 
inhibitors of the cyclooxygenase and/or lipoxygenase meta- 
bolic pathways (Table 11). Drugs which inhibited  both path- 
ways (BW755 and nordihydroguaiaretic acid; Blackwell and 
Flower, 1978; Hamberg, 1976; Higgs et al., 1979) blocked the 
synthesis of the cyclooxygenase metabolites (6-keto-PGF1,, 
PGF2,, and PGE,) as well as of the lipoxygenase metabolite 
5-HETE  and of the unidentified metabolite (LM of Fig. 1, 
Table 11). Esculetin (Sekiya et al., 1982; Neichi et al., 1983) 
and baicalein (Sekiya and Okuda, 1982), presumed selective 
lipoxygenase inhibitors, also blocked the synthesis of 5-HETE 
and  the unidentified metabolite, but actually increased the 
synthesis of cyclooxygenase metabolites of arachidonic acid. 
In contrast, indomethacin (Flower, 1974) a t  low concentra- 
tions decreased the synthesis of the cyclooxygenase metabo- 
lites, but not 5-HETE  or  the unidentified metabolite. These 
results suggest that  the unidentified arachidonic acid metab- 
olite is a lipoxygenase metabolite. 
Ionophore Stimulation of Arachidonic Acid Liberation and 
Metabolism-The divalent  cation ionophore, A23187  (2.5 PM), 
stimulated the liberation of arachidonic acid from C62B cel- 
lular glycerolipids in a  time-dependent manner (Fig. 4). There 
were, however, several significant differences between the 
response to cholinergic stimulation and that to ionophore 
TABLE I1
Inhibition of C62B cell  arachidonate  metabolism 
Metabolite 
% of control' 
NDGA,'  20 p M  O f 1  O f 3  O f 3  1 6 f 6  
BW755, 100 p M  2 f 2  O f 5  O f 1  O f 2  
Baicalein, 5OpM 1 5 5 f  23 1 7 2 k 3 2  2 +  1 7 5 4  
Esculetin, 100 p~ 230 f 38 266 f 31 18 f 6 27 f 8 
Indomethacin, 1.0 p~ 8 + 4.0 9 f 5 80 f 14 73 f 5 
Indomethacin. 0.1 UM 39 f 10 51 f 12 105 f 22 115 f 10 
* LM, lipoxygenase metabolite. 
* Values, expressed as the percentage of drug vehicle-treated ho- 
mogenates corrected for nonenzymatic metabolism of arachidonic 
acid, are the mean + S.E. for three experiments performed  in dupli- 
cate. The median net production by control homogenates (ionophore 
in the absence of inhibitors) was: PGEZ, 3242; 6-keto-PGF1,/PGF2,, 
1507; 5-HETE, 2027; and lipoxygenase metabolite, 2467  cpm respec- 
tively. These values are corrected for nonenzymatic production of 
metabolites by heat-inactivated homogenates, these values ranged 
from  335 to 580 cpm. 













FIG. 4. Autoradiograph  of arachidonic acid and its metab- 
olites  at various times following application of the ionophore 
A23187. Cultures of prelabeled C62B cells were incubated in the 
presence of 2.5 p~ A23187 for times indicated. Controls included 
cultures incubated for 1 min without the ionophore or with 1.0 mM 
acetylcholine substituted for ,423187.  Abbreviations  are as in Fig. 1. 
A23187 treatment. Most marked was the observation that, 
while arachidonic acid accumulation in response to acetylcho- 
line stimulation peaked at  60-90 s and  then fell rapidly, the 
levels of radioactive arachidonic acid liberated  in response to 
ionophore continued to rise during the  entire course of the 
incubation (Fig. 4 and Table 111). Second, although following 
acetylcholine stimulation there was only one major radioac- 
tive eicosanoid accumulated, a lipoxygenase metabolite, the 
ionopore additionally induced the formation of HHT, PGE2, 
PGD,, 6-keto-PGF1,, and PGF,,. During  a 1-min incubation 
with A23187, unesterified arachidonic acid, HHT, 6-keto- 
PGF1,, PGF,,, and a lipoxygenase metabolite accumulated; 
with a longer incubation, the accumulation of PGE2, PGD2, 
5-HETE,  and  12-HETE was also detectable. Finally, whereas 
during cholinergic stimulation the accumulation of radioac- 
tive arachidonic acid and phosphatidic acid occurred nearly 
simultaneously, in  ionophore-stimulated cells the accumula- 
tion of unesterified [ 1-'*C]arachidonic acid consistently  pre- 
ceded the increase in radioactive phosphatidic acid (Fig. 4 and 
Table 111). 
DISCUSSION 
Our data demonstrate that in C62B  glioma cells, the release 
of arachidonic acid and formation of phosphatidic acid in 
response to cholinergic agonists is rapid, transient, dependent 
upon the activation of a specific class of muscarinic receptors, 
and leads to selective production of certain eicosanoids. The 
importance of these  results lies in their implication for the 
physiological significance of arachidonic acid metabolism in 
glial responses to neurotransmitters. 
The time course of the response suggests that glia are 
capable of a  rapid response to neuronal activity and could act 
quickly to affect the extracellular environment of neurons. 
The time course of this modulation would not be sufficiently 
rapid to affect the neuronal signal which initiated the glial 
response, but could result  in an altered  neuronal response to 
subsequent  stimulation. In  other systems, it  has been shown 
that certain physiological processes are coupled to rapid ara- 
chidonic acid release and metabolism, e.g. secretion of insulin 
by endocrine islet cells (Dunlop and Larkins, 1984), platelet 
secretion and aggregation (Lapetina  and Cuatrecasas, 1979; 
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TABLE 111 
Liberation of arachidonic acid and  formation  of  arachidonate  metabolites  following  stimulation  of C62B glioma cells 
with  acetylcholine  and  the  ionophore A23187 
Cultures of C62B cells prelabeled with [1-’*C]arachidonic acid (AA) were treated with acetylcholine (Ach 1 mM) 
or the ionophore A23187  (2.5 NM) for the times indicated. Control cultures were incubated for 1 min in the absence 
of acetylcholine or ionophore. Lipids were extracted and prepared as detailed under “Methods.” Values, expressed 
in cpm/culture, are the mean f S.E. for  five or more cultures. 
Products 
Treatment 
Control 1 min Ach 15 min Ach 1 min 15 min A23187 
AA 1285 f 107  3015 k 308 1835 k 300  2755 k 390  4020 k 643 
6-Keto-PGF1, and PGFz,’ 660 f 135 667 k 93 645 k 113 1825 f 297  2050 f 412 
202 f 60 200 k 15 258 k 30  25  f 30  360 f 42 
123 k 15 
LMb 
120 k 15 
223 k 15 
145 f 13 160 f 19 
470 f 52  320 f 63 
290 f 15 
5-HETE 
417 f 48 
302 k 13 282 f 18 402 f 88 
490 f 47 
HHT 175 k 13 180 f 16 
385 k 20 585 k 60 
290 k 68 
12-HETE 300 f 35 252 k 43 
342 k 27 618 k 75 
368 k 43  365 f 42 
4390 f 578 
865 f 73 
PGEZ 
PGDZ 
PA’ 3255 f 270 5465 t 627 3877 f 462  65 7 & 885 
“Resolution of PGF2, and 6-keto-PGF1, into separate bands (see “Methods”) indicated that after a 15-min 
exposure to ionophore, 76 and 24% of the radioactivity co-chromatographed with PGFz, and 6-keto-PGF1,, 
respectively. 
LM, lipoxygenase metabolite. 
e PA, phosphatic acid. 
Lapetina, 1982), and  neutrophil activation (Cockcroft et al., 
1981). 
The transitory nature of the arachidonic acid liberation 
and phosphatidic acid formation following exposure to cholin- 
ergic agonists is as might be expected of a physiologically 
significant response to neurotransmitter release by neurons. 
The mechanism of this  transient accumulation might initially 
involve a liberation of arachidonic acid from phospholipids 
via the rapid activation of a phospholipase Az (Bills et al., 
1976; Billah et al., 1981, Lapetina, 1983) or possibly diglycer- 
ide and monoglyceride lipases (Bell et aL, 1979; Rittenhouse- 
Simmons, 1979, Prescott  and Majerus, 1983). This would  be 
followed  by a  rapid re-acylation of the free arachidonic acid 
(Walsh et al., 1983). The similar time course for accumulation 
of the unidentified lipoxygenase metabolite suggests that  this 
product is rapidly made from liberated arachidonic acid, al- 
though the possibility that  it is rapidly released independently 
from a pre-existing esterified store has not been eliminated. 
It would then be either rapidly degraded or removed  by a re- 
acylation reaction similar to  that reported to occur for some 
other lipoxygenase products  (Stenson  and  Parker, 1979; 
Walsh et al., 1981; Bonser et al., 1981). 
We assume that  the formation of phosphatidic acid reflects 
the action of phospholipase C  on  the inositol phospholipids 
to yield 1,2-diacylglycerol and  a subsequent phosphorylation 
by 1,2-diacylglycerol kinase to form phosphatidic acid (La- 
petina  and Cuatrecasas, 1979; Lapetina, 1982). The phospho- 
lipase C activity reflected by this elevation of radioactive 
phosphatidic acid may  be directly relevant to  the elevation of 
radioactive arachidonic acid (e.g. via diglyceride and mono- 
glyceride lipases, Bell et al., 1979; Rittenhouse-Simmons, 
1979; Prescott and Majerus, 1983, or a phosphatidic acid- 
specific phospholipase A*, Billah et al., 1981). Another possi- 
bility is that  the formation of phosphatidic acid and other 
metabolites resulting from phospholipase C action may sub- 
serve some independent functions. In  this regard, phospha- 
tidic acid has been recognized as a Ca2+ ionophore (Tyson et 
al., 1976; for review see Lapetina, 1982) and  in neuroblastoma 
cells has been shown to stimulate calcium influx and  cGMP 
synthesis (Ohsako and Deguchi, 1981). Muscarinic stimula- 
tion of phospholipase C is well documented in neural  tissues 
(Berridge et al., 1982; Fisher and Agranoff,  1980; Brown et al., 
1984) and has recently been demonstrated in astrocytoma 
cells (Masters et al., 1984). 
The specificity of this response for muscarinic receptors 
was demonstrated by the ability of the muscarinic receptor 
antagonist,  atropine,  but  not the nicotinic receptor antago- 
nist, d-tubocurarine, to block the action of acetylcholine. 
Interestingly, in  contrast to the  potent effects of carbachol 
and acetylcholine, the muscarinic receptor agonists, oxotre- 
morine and pilocarpine, failed to stimulate arachidonic acid 
liberation. This is consistent with similar observations in 
several cell types demonstrating heterogeneity of muscarinic 
receptors (see Birdsall and Hulme, 1983). Especially relevant 
is the observation that,  in  heart cell cultures, one class (or 
state) of muscarinic receptors is linked to stimulation of 
inositol phospholipid metabolism, while a second is linked to 
inhibition of adenylate cyclase (Brown and Brown, 1984). 
Only the  latter receptor system is activated by oxotremorine 
and pilocarpine, while carbachol and acetylcholine activate 
both receptor systems. 
The selective effect of cholinergic receptor activation on 
arachidonic acid metabolism is apparent in the specific accu- 
mulation of a specific lipoxygenase metabolite. No other 
lipoxygenase metabolite accumulates in response to cholin- 
ergic receptor occupation nor does there appear to be  accel- 
erated production of cyclooxygenase metabolites. (Note that 
there is accumulation of another lipoxygenase metabolite, 5- 
HETE, in the culture medium during the 18-h prelabeling 
period, but  its formation does not appear to be regulated by 
cholinergic stimulation.) Relatively little is known of the 
action of lipoxygenase metabolites on the nervous system, 
although recent evidence suggests that they may serve an 
important role (Palmer et al., 1981). Furthermore, it has been 
demonstrated  in  a murine neuroblastoma cell line, N1E-115, 
that elevation of cGMP levels by cholinergic stimulation is 
dependent upon arachidonic acid metabolism along the lipox- 
ygenase pathway (Snider et al., 1984). It is noteworthy that 
in other cell types, the formation of lipoxygenase metabolites 
of arachidonic acid is often associated with stimulation of 
secretory responses (Walenga et al., 1980; Metz et al., 1983). 
The accumulation of prostaglandins within minutes of ion- 
ophore stimulation (see Fig. 3) indicates that C62B cells have 
the capacity to rapidly produce cyclooxygenase metabolites. 
The ability of these cells to produce cyclooxygenase metabo- 
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